Growth N. V. Biotech, 10% Owner at Radius Health, Inc. (RDUS), bought 50,000 shares at $29.15 ($1.5M) on 2017-11-03, disclosed to the SEC on 2017-11-07.
Open-market purchase of $1.5M RDUS by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| Filing → |
| BDTX | BUY | 2023-06-29 | $9.6M | — | Filing → |
| BDTX | BUY | 2022-11-02 | $449K | — | Filing → |
| EPIX | BUY | 2022-10-28 | $8.2M | — | Filing → |